Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Type III hypersensitivity"'
Autor:
Rebecca R. Meredith, Pooja Patel, Polly Huang, Chinelo Pamela Onyenekwu, Herleen Rai, Jody Tversky, Santiago Alvarez-Arango
Publikováno v:
Frontiers in Allergy, Vol 5 (2024)
Insulin-induced type III hypersensitivity reactions (HSRs) are exceedingly rare and pose complex diagnostic and management challenges. We describe a case of a 43-year-old woman with type 1 diabetes mellitus (DM), severe insulin resistance, and subcut
Externí odkaz:
https://doaj.org/article/e238616cf291438a8befee20a2b52141
Autor:
Hyeok-Jin Kwon, MD, Jung-Hwan Kim, MD, Dong-Wha Yoo, MD, Tae-Hoon Kim, MD, Jung-Ho Yoon, MD, Ki-Ho Kim, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 16, Iss , Pp 101-104 (2021)
Externí odkaz:
https://doaj.org/article/c13a62d55e21444fbd0fa85e9d279029
Publikováno v:
IDCases, Vol 29, Iss , Pp e01536- (2022)
Purpose: To describe a novel case of marginal keratitis following COVID 19 vaccination. Methods: Case report Results: A 68-year-old female received the Moderna COVID 19 vaccine. She then developed ocular irritation and peripheral corneal opacities th
Externí odkaz:
https://doaj.org/article/68e1cb61ed284c5487261157b13895a4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
JAAD Case Reports
JAAD Case Reports, Vol 16, Iss, Pp 101-104 (2021)
JAAD Case Reports, Vol 16, Iss, Pp 101-104 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b748e65b4a121d66be0faae004ed21
http://europepmc.org/articles/PMC8441105
http://europepmc.org/articles/PMC8441105
Autor:
Flaubert Alexis Pérez-Noriega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, José Jiram Torres-Ruíz, José Luis Maravillas-Montero, Mauricio Castañón-Arreola, María Elena Hernández-Campos, Cesar Rodríguez-Balderas, Beatriz Victoria Basurto-López, Carlos Peñafiel-Salgado, Ana Paola Espinosa-García, José Alberto Choreño-Parra, Martha Lilia Tena-Suck, Luis O. Soto-Rojas, Elsa Y. León-Marroquín, José Pablo Romero-López, Manuel Castillejos-López
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 2; Pages: 1242
Tuberculosis (TB) of the central nervous system (CNS) presents high mortality due to brain damage and inflammation events. The formation and deposition of immune complexes (ICs) in the brain microvasculature during Mycobacterium tuberculosis (Mtb) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d815488e78aed603eccc1b314b40dca
Potential New Treatments for Kawasaki Disease, Its Variations, and Multisystem Inflammatory Syndrome
Autor:
Roe, Kevin
Publikováno v:
Sn Comprehensive Clinical Medicine
The causation of Kawasaki disease has been a medical mystery for over 54 years. However, the causations of Kawasaki disease, its variations, and COVID-19-associated Multisystem Inflammatory Syndrome have been recently explained to involve high replic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b592d8228355e4de2c2472b2cd76823
https://doi.org/10.1007/s42399-021-00872-w
https://doi.org/10.1007/s42399-021-00872-w
Autor:
Graham Paul, Stuart W. Naylor, Nicholas P. Macri, Scott Manetz, Richard Haworth, A. Peter Hall, David Jones, Thierry Flandre, Jeffrey S. Tepper, Michela Gregori, Annick Cauvin, Molly H. Boyle, Sydney Mukaratirwa, Alison Wolfreys, Renaud Fleurance, Inge Tarnow, Kristen J. Nikula, Alessandro Piaia, Mark Price, Ian Robinson, Andrew Allen, Tom Gelzleichter, Mark C Freke, Karyn Colman, Andreas M Hohlbaum, Maurice G Cary
Publikováno v:
Toxicologic Pathology. 49:235-260
The inhalation route is a relatively novel drug delivery route for biotherapeutics and, as a result, there is a paucity of published data and experience within the toxicology/pathology community. In recent years, findings arising in toxicology studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::507bdc0e870c9ffe85569d58c5326be1
https://doi.org/10.1177/0192623320976094
https://doi.org/10.1177/0192623320976094
Publikováno v:
Toxicon. 186:42-45
Two antivenoms are available for rattlesnake envenomations in the U.S., Fab (CroFab®, BTG, UK), and F(ab’)2 (Anavip®, Bioclon, Mexico) antivenom (AV) with F(ab’)2AV released in October 2018. The F(ab’)2AV Phase 3 comparative clinical trial de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16d7415e8d4ad45094d78d4a8611a55d
https://doi.org/10.1016/j.toxicon.2020.08.002
https://doi.org/10.1016/j.toxicon.2020.08.002